Evidence map›Paper›PMID 41774893›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2026

[Hepatic encephalopathy from cholangitis in a young patient with ornithine transcarbamylase mutation].

Yareli Lizbeth Rojas-Salazar, Emiliano Gómez-Montañez, Jorge Gustavo Rojas-Salazar

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yareli Lizbeth Rojas-SalazarUniversidad Autónoma de Ciudad Juárez, Instituto de Ciencias Biomédicas, Programa de Médico Cirujano. Ciudad Juárez, Chihuahua, México.ORCID 0000-0003-1953-4857
Emiliano Gómez-MontañezUniversidad Autónoma de Ciudad Juárez, Instituto de Ciencias Biomédicas, Programa de Médico Cirujano. Ciudad Juárez, Chihuahua, México.ORCID 0000-0002-5611-3798
Jorge Gustavo Rojas-SalazarUniversidad Autónoma de Ciudad Juárez, Instituto de Ciencias Biomédicas, Programa de Médico Cirujano. Ciudad Juárez, Chihuahua, México.ORCID 0009-0005-5506-8082

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatic encephalopathy (HE) is a serious neurological complication of chronic liver failure characterized by alterations of consciousness ranging from mild confusion to coma; and although it is classically associated with hyperammonemia secondary to hepatic dysfunction, in some patients genetic or metabolic susceptibilities may coexist. Clinical case: This report presents a 37-year-old male patient who was admitted to the emergency department due to altered mental status, severe hyperbilirubinemia, acute renal dysfunction, and signs of decompensated liver failure; therefore, the diagnosis of hepatic encephalopathy triggered by cholangitis was established. During hospitalization, the patient exhibited disproportionate hyperammonemia relative to the degree of hepatic dysfunction, and genetic analysis revealed a heterozygous variant in the ornithine transcarbamylase (OTC) gene and multidisciplinary treatment was initiated to reduce ammonia. Conclusion: This case allows us to reflect on the diagnostic and therapeutic challenges of HE, as well as the importance of a comprehensive approach in patients with advanced liver disease. Furthermore, it demonstrates how genetic defects of the urea cycle, such as partial OTC deficiency, can aggravate hyperammonemia and encephalopathy.

Indexed as

CholangitisHepatic EncephalopathyMutationOrnithine CarbamoyltransferaseOrnithine Carbamoyltransferase Deficiency DiseaseAdultHumansMaleOrnithine CarbamoyltransferaseAlcoholismo CrónicoCase ReportCholangitisChronic AlcoholismColangitisEncefalopatía HepáticaHepatic EncephalopathyHepatic InsufficiencyInsuficiencia HepáticaReporte de Caso

Identifiers

PMID41774893
PMCPMC13068355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.